Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2018-02-22 | 2017-08-24 |
| Drug Identification Number | 02382814 | 02382814 |
| Brand name | TOBRAMYCIN INJECTION, USP | TOBRAMYCIN INJECTION, USP |
| Common or Proper name | TOBRAMYCIN INJECTION, USP | TOBRAMYCIN INJECTION, USP |
| Company Name | MYLAN PHARMACEUTICALS ULC | MYLAN PHARMACEUTICALS ULC |
| Ingredients | TOBRAMYCIN | TOBRAMYCIN |
| Strength(s) | 40MG | 40MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 2mL 10VL, 30mL 1VL | 2mL 10VL, 30mL 1VL |
| ATC code | J01GB | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2018-03-01 | |
| Actual discontinuation date | 2017-08-23 | |
| Remaining supply date | 2018-03-01 | 2017-08-23 |
| Discontinuation status | Reversed | Discontinued |
| Discontinuation decision reversal | yes | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |